Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS · Delayed Price · Currency is USD
0.0007
-0.0003 (-30.00%)
Feb 12, 2026, 1:49 PM EST
Innovation Pharmaceuticals Employees
Innovation Pharmaceuticals had 4 employees as of June 30, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$655,000
Market Cap
370.14K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2023 | 4 | 0 | - |
| Jun 30, 2022 | 4 | 0 | - |
| Jun 30, 2021 | 4 | 0 | - |
| Jun 30, 2020 | 4 | 0 | - |
| Jun 30, 2019 | 4 | -4 | -50.00% |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Hepion Pharmaceuticals | 22 |
| Altamira Therapeutics | 11 |
| Bio-Path Holdings | 10 |
| Avenue Therapeutics | 2 |
| Actavia Life Sciences | 1 |
Innovation Pharmaceuticals News
- 2 years ago - Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024 - GlobeNewsWire
- 2 years ago - Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases - GlobeNewsWire
- 2 years ago - Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin's Potential for Treating Fungal Keratitis - GlobeNewsWire